In the News
April 26, 2021
The Advancing Education on Biosimilars Act of 2021 authorizes the Food and Drug Administration to educate consumers and health care providers on the benefits of biosimilar medications.
April 23, 2021
The Biosimilars Council strongly supports the reintroduction, and encourages swift passage, of the bipartisan BIOSIM Act (HR 2815).
February 22, 2021
The Association for Accessible Medicines (AAM) and its Biosimilars Council shared their policy priorities for the Biden administration and 117th Congress, highlighting solutions to maintain the sustainability of generic and biosimilar competition.
November 15, 2020
IGBA launched the first ever Global Biosimilars Week, which is aimed at raising the awareness of biosimilar medicines worldwide through a globally aligned educational initiative.
June 3, 2020
A new report from Matrix Global Advisors (MGA) details “lessons learned” from the European biosimilars experience that can improve access to these medicines for America’s patients.
January 28, 2020
The Biosimilars Council applauds the FDA for streamlining requirements for approval of biosimilar and interchangeable insulin based on sound science.
